Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CARM1 | Q86X55 | 1/20 | 0.78 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.78 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.78 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.65 |
| ▸ | MAOB | P27338 | 4/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL18730544 | 0.98 | CARM1 (0.75) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL4604745 | 0.94 | CARM1 (0.75) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL25688953 | 0.92 | CARM1 (0.72) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL8342032 | 0.92 | CARM1 (0.72) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| Hydrochloric Acid SCHEMBL9373710 | 0.92 | CARM1 (0.72) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL1395704 | 0.88 | CARM1 (1.00) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL1088446 | 0.87 | SIGMAR1 (0.74) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| Hydrochloric Acid SCHEMBL17372655 | 0.86 | CARM1 (0.96) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| Hydrochloric Acid SCHEMBL1087168 | 0.85 | SIGMAR1 (0.71) | CARM1PRMT6PRMT8SIGMAR1MAOB | |
| SCHEMBL29733117 | 0.85 | SIGMAR1 (0.85) | CARM1PRMT6PRMT8SIGMAR1MAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328093-B2 | Selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications | HYBRIGENICS SA (FR) | 2016-05-03 | — | — | US | claimed |
| US-20150072973-A1 | NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS | HYBRIGENICS SA (FR) | 2015-03-12 | — | — | US | claimed |
| CN-101045759-B | Styrene or substituted styrene polymer type quaternary ammonium salt antistat or bacterial agent and preparation method thereof | DINGLAN GREEN CHEMICAL INST CO LTD CHANGZHOU | 2011-06-01 | — | — | CN | claimed |
| CN-101045759-A | Styrene or substituted styrene polymer type quaternary ammonium salt antistat or bacterial agent and preparation method thereof | DINGLAN GREEN CHEMICAL INST CO (CN) | 2007-10-03 | — | — | CN | claimed |
| EP-0427765-B1 | ALKOXY-4(1H)-PYRIDONE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR USE AS DRUGS | GOEDECKE AG (DE) | 2000-01-05 | — | — | EP | claimed |
| US-5185352-A | Treating or preventing cardiovascular disorders | GOEDECKE AKTIENGESELLSCHAFT (DE) | 1993-02-09 | — | — | US | claimed |
| US-12378255-B2 | Toll-like receptor antagonist compounds and methods of use | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-20240182478-A1 | TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE | DYNAVAX TECHNOLOGIES CORPORATION | 2024-06-06 | — | — | US | disclosed |
| CN-114651025-B | Curable composition, cured product, fiber-reinforced composite material, molded article, and method for producing same | DIC株式会社 | 2024-06-04 | — | — | CN | disclosed |
| US-20240101584-A1 | TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES | Westlake University (CN) | 2024-03-28 | — | — | US | disclosed |
| CN-117157281-A | Targeted delivery of 1,2,4, 5-tetraoxacompounds and uses thereof | 西湖大学 | 2023-12-01 | — | — | CN | disclosed |
| US-11827641-B2 | Toll-like receptor antagonist compounds and methods of use | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827641-B2 | Toll-like receptor antagonist compounds and methods of use | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2023-11-28 | — | — | US | disclosed |
| EP-0061673-B1 | ISOQUINOLINESULFONYL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1984-10-24 | — | — | EP | disclosed |
| US-4456757-A | MUSCLE RELAXANTS, VASODILATORS, HYPOTENSIVE AGENTS | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1984-06-26 | — | — | US | disclosed |
| EP-0061673-A1 | Isoquinolinesulfonyl derivatives and process for the preparation thereof | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1982-10-06 | — | — | EP | disclosed |
| EP-0014899-B1 | PROCESS FOR THE PREPARATION OF CATIONIC ANTHRAQUINONE DYES | BAYER AG (DE) | 1981-10-21 | — | — | EP | disclosed |
| US-4296044-A | AMINATION, QUATERNIZATION | BAYER AKTIENGESELLSCHAFT (DE) | 1981-10-20 | — | — | US | disclosed |
| EP-0014899-A1 | Process for the preparation of cationic anthraquinone dyes | BAYER AG (DE) | 1980-09-03 | — | — | EP | disclosed |
| US-4091001-A | Liquid coating compositions containing glycidyl ester-polyamine binders | CHEMISCHE WERKE HUELS AKTIENGESELLSCHAFT (DT) | 1978-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240182478-A1 | TOLL-LIKE RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USE | TLR7, TLR9, TLR1 | CARM1 2881/4885PRMT6 4139/4885PRMT8 1856/4885 |
| US-20240101584-A1 | TARGETED DELIVERY OF 1,2,4,5 TETRAOXANE COMPOUNDS AND THEIR USES | AIFM2, GPX1, GPX4 | CARM1 1324/4885PRMT6 2107/4885PRMT8 2023/4885 |
| US-11827641-B2 | Toll-like receptor antagonist compounds and methods of use | TLR7, TLR9, TLR1 | CARM1 2881/4885PRMT6 4139/4885PRMT8 1856/4885 |
| US-12378255-B2 | Toll-like receptor antagonist compounds and methods of use | TLR7, TLR9, TLR1 | CARM1 2881/4885PRMT6 4139/4885PRMT8 1856/4885 |
| US-20150072973-A1 | NOVEL SELECTIVE INHIBITORS OF UBIQUITIN SPECIFIC PROTEASE 7, THE PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR THERAPEUTIC APPLICATIONS | USP7, SENP7, PSMA7 | CARM1 3263/4885PRMT6 1702/4885PRMT8 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.